A new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy drug, and atezolizumab, an ...

BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...

Colorectal cancer (CRC) is one of the most common malignant cancers and its incidence is steadily rising particularly in ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in genetically defined patients. A team of researchers led by Karolinska Institutet and Karolinska University Hospital has demonstra ...

NG-350A has received FDA fast track designation for mismatch repair-proficient locally advanced rectal cancer, addressing a ...

Cancer rates in young people are growing, and those in the GI tract are rising fastest of all. Here are five things to know about colorectal cancer from an expert.

An international team of researchers has uncovered a promising new avenue for treating colorectal cancer, the world's third ...

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of ...

Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced CRC and KRAS G12D Inhibitor in Advanced ...

John Becker and Megan Scott had been married eight years when John was diagnosed with rectal cancer. They explain how the ...

Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that ...

Recently diagnosed with colorectal cancer? Here's how to tell your boss and HR about your colorectal cancer diagnosis and ...